The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)

R Mirzaei, A Attar, S Papizadeh, AS Jeda… - Archives of …, 2021 - Springer
COVID-19 is an acute respiratory infection accompanied by pneumonia caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has affected millions of …

COVID-19 and heme oxygenase: novel insight into the disease and potential therapies

PL Hooper - Cell Stress and Chaperones, 2020 - Springer
The COVID-19 pandemic needs therapies that are presently available and safe. We propose
that subjects with metabolic syndrome, old age, and male gender have the greatest …

COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism

L Wenzhong, L Hualan - 2020 - chemrxiv.org
The novel coronavirus pneumonia is a contagious acute respiratory disease caused by the
SARS-COV-2 coronavirus. The pathogenic mechanism of the novel coronavirus is unknown …

Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19

G d'Ettorre, G Ceccarelli, M Marazzato… - Frontiers in …, 2020 - frontiersin.org
Background: Gastrointestinal disorders are frequent in COVID-19 and SARS-CoV-2 has
been hypothesized to impact on host microbial flora and gut inflammation, infecting intestinal …

Oral bacteriotherapy in patients with COVID-19: a retrospective cohort study

G Ceccarelli, C Borrazzo, C Pinacchio… - Frontiers in …, 2021 - frontiersin.org
Background: Mounting evidence suggests SARS-CoV-2 may impact on host microbiota and
gut inflammation, infecting intestinal epithelial cells. This possible link and its implications …

SARS-CoV-2 proteins bind to hemoglobin and its metabolites

GC Lechuga, F Souza-Silva, CQ Sacramento… - International journal of …, 2021 - mdpi.com
(1) Background: coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been linked to hematological dysfunctions, but …

Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications

D Singh, H Wasan, KH Reeta - Free Radical Biology and Medicine, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) continues to infect hundred thousands of people …

COVID‐19 metabolism: Mechanisms and therapeutic targets

T Wang, Y Cao, H Zhang, Z Wang, CH Man… - MedComm, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) dysregulates antiviral
signaling, immune response, and cell metabolism in human body. Viral genome and …

Dengue virus targets Nrf2 for NS2B3-mediated degradation leading to enhanced oxidative stress and viral replication

M Ferrari, A Zevini, E Palermo, M Muscolini… - Journal of …, 2020 - Am Soc Microbiol
Dengue virus (DENV) is a mosquito-borne virus that infects upward of 300 million people
annually and has the potential to cause fatal hemorrhagic fever and shock. While the …

The neat dance of COVID-19: NEAT1, DANCR, and co-modulated cholinergic RNAs link to inflammation

C Meydan, N Madrer, H Soreq - Frontiers in immunology, 2020 - frontiersin.org
The COVID-19 pandemic exerts inflammation-related parasympathetic complications and
post-infection manifestations with major inter-individual variability. To seek the …